Jon D. Larson

3.1k total citations · 1 hit paper
29 papers, 2.0k citations indexed

About

Jon D. Larson is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Jon D. Larson has authored 29 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Jon D. Larson's work include Glioma Diagnosis and Treatment (6 papers), Angiogenesis and VEGF in Cancer (4 papers) and Zebrafish Biomedical Research Applications (4 papers). Jon D. Larson is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Angiogenesis and VEGF in Cancer (4 papers) and Zebrafish Biomedical Research Applications (4 papers). Jon D. Larson collaborates with scholars based in United States, Germany and Canada. Jon D. Larson's co-authors include Stephen C. Ekker, Aidas Nasevicius, Steven Farber, Soraya Beiraghi, Charles Brenner, Eleanor Y. Chen, Karl J. Clark, Perry B. Hackett, Jeffrey J. Essner and David A. Largaespada and has published in prestigious journals such as Blood, Bioinformatics and The Journal of Immunology.

In The Last Decade

Jon D. Larson

27 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

p53 Activation by Knockdown Technologies

2007 818 citations Jon D. Larson, Aidas Nasevicius et al. PLoS Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jon D. Larson United States	16	1.5k	790	324	220	192	29	2.0k
Sarah Farrington United States	10	2.0k 1.3×	930 1.2×	378 1.2×	175 0.8×	202 1.1×	11	2.5k
Cristi L. Stoick-Cooper United States	10	1.5k 1.0×	365 0.5×	240 0.7×	167 0.8×	157 0.8×	10	2.0k
Jason R. Jessen United States	20	1.3k 0.9×	871 1.1×	262 0.8×	184 0.8×	139 0.7×	32	1.7k
Jeffrey R. Guyon United States	23	2.0k 1.3×	613 0.8×	251 0.8×	122 0.6×	184 1.0×	43	2.6k
Claudia Gerri United Kingdom	12	1.5k 1.0×	561 0.7×	384 1.2×	189 0.9×	170 0.9×	16	2.1k
Salim Abdelilah‐Seyfried Germany	31	1.9k 1.3×	827 1.0×	225 0.7×	194 0.9×	130 0.7×	75	2.6k
Andrew J. Waskiewicz Canada	24	2.3k 1.6×	498 0.6×	480 1.5×	178 0.8×	306 1.6×	48	2.9k
Johan Ledin Sweden	18	1.5k 1.0×	1.2k 1.5×	385 1.2×	158 0.7×	273 1.4×	28	2.2k
Roland Dosch Germany	19	2.0k 1.3×	461 0.6×	440 1.4×	144 0.7×	83 0.4×	33	2.5k
Martin Gering United Kingdom	19	1.4k 1.0×	1.1k 1.3×	154 0.5×	178 0.8×	361 1.9×	28	1.9k

Countries citing papers authored by Jon D. Larson

Since Specialization

Citations

This map shows the geographic impact of Jon D. Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon D. Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon D. Larson more than expected).

Fields of papers citing papers by Jon D. Larson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon D. Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon D. Larson. The network helps show where Jon D. Larson may publish in the future.

Co-authorship network of co-authors of Jon D. Larson

This figure shows the co-authorship network connecting the top 25 collaborators of Jon D. Larson. A scholar is included among the top collaborators of Jon D. Larson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon D. Larson. Jon D. Larson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Larson, Jon D., Darren Finlay, Rabi Murad, et al.. (2024). EPEN-26. DRUG SCREENING IN PATIENT-DERIVED MODELS OF POSTERIOR FOSSA A EPENDYMOMA REVEALS NOVEL PHARMACOLOGICAL VULNERABILITIES. Neuro-Oncology. 26(Supplement_4). 0–0.

Zhang, Wenqiu, Ju‐Hee Oh, Wenjuan Zhang, et al.. (2023). Central Nervous System Distribution of Panobinostat in Preclinical Models to Guide Dosing for Pediatric Brain Tumors. Journal of Pharmacology and Experimental Therapeutics. 387(3). 315–327. 3 indexed citations

Kuzuoğlu‐Öztürk, Duygu, Ozlem Aksoy, Christin Schmidt, et al.. (2022). N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma. Cancer Research. 83(1). 130–140. 6 indexed citations

Larson, Jon D., Kyle Ford, Daniella McDonald, et al.. (2021). Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures. Biomaterials. 280. 121276–121276. 6 indexed citations

Wang, Shanqing, Jens Luebeck, Alexandra Garancher, et al.. (2021). Abstract 95: The landscape of extrachromosomal circular DNA in medulloblastoma subgroups. Cancer Research. 81(13_Supplement). 95–95.

Larson, Jon D. & Suzanne J. Baker. (2018). Engineering Inducible Knock-In Mice to Model Oncogenic Brain Tumor Mutations from Endogenous Loci. Methods in molecular biology. 1869. 207–230. 2 indexed citations

Zhu, Guo, Sherri L. Rankin, Jon D. Larson, et al.. (2016). PTEN Signaling in the Postnatal Perivascular Progenitor Niche Drives Medulloblastoma Formation. Cancer Research. 77(1). 123–133. 14 indexed citations

Heltemes-Harris, Lynn, Jon D. Larson, Timothy K. Starr, et al.. (2015). Sleeping Beauty transposon screen identifies signaling modules that cooperate with STAT5 activation to induce B-cell acute lymphoblastic leukemia. Oncogene. 35(26). 3454–3464. 22 indexed citations

Chiou, Pinwen Peter, et al.. (2013). Production of Homozygous Transgenic Rainbow Trout with Enhanced Disease Resistance. Marine Biotechnology. 16(3). 299–308. 31 indexed citations

10.

Larson, Jon D., Troy A. McEachron, Chunxu Qu, et al.. (2013). Abstract A15: Variant histone H3 mutations associate with histone modification, DNA methylation, and gene expression changes in pediatric high-grade gliomas. Cancer Research. 73(13_Supplement). A15–A15. 1 indexed citations

11.

Bender, Aaron M., Lara S. Collier, Fausto J. Rodríguez, et al.. (2010). Sleeping Beauty –Mediated Somatic Mutagenesis Implicates CSF1 in the Formation of High-Grade Astrocytomas. Cancer Research. 70(9). 3557–3565. 52 indexed citations

12.

Adhikari, Neeta, David L. Basi, DeWayne Townsend, et al.. (2010). Heparan sulfate Ndst1 regulates vascular smooth muscle cell proliferation, vessel size and vascular remodeling. Journal of Molecular and Cellular Cardiology. 49(2). 287–293. 23 indexed citations

13.

Wiesner, Stephen M., Stacy A. Decker, Jon D. Larson, et al.. (2009). De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA. Cancer Research. 69(2). 431–439. 119 indexed citations

14.

Larson, Jon D., Aidas Nasevicius, Soraya Beiraghi, et al.. (2007). p53 Activation by Knockdown Technologies. PLoS Genetics. 3(5). e78–e78. 818 indexed citations breakdown →

15.

Pickart, Michael A., Eric W. Klee, Sridhar Sivasubbu, et al.. (2006). Genome-Wide Reverse Genetics Framework to Identify Novel Functions of the Vertebrate Secretome. PLoS ONE. 1(1). e104–e104. 68 indexed citations

16.

Larson, Jon D., Eleanor Y. Chen, Karl J. Clark, et al.. (2004). Expression of VE‐cadherin in zebrafish embryos: A new tool to evaluate vascular development. Developmental Dynamics. 231(1). 204–213. 87 indexed citations

17.

Sumanas, Saulius, et al.. (2003). Zebrafish chaperone protein GP96 is required for otolith formation during ear development. Developmental Biology. 261(2). 443–455. 31 indexed citations

18.

Ekker, Stephen C. & Jon D. Larson. (2001). Morphant technology in model developmental systems. genesis. 30(3). 89–93. 212 indexed citations

19.

Nasevicius, Aidas, Jon D. Larson, & Stephen C. Ekker. (2000). Distinct Requirements for Zebrafish Angiogenesis Revealed by aVEGF-AMorphant. Yeast. 1(4). 294–301. 216 indexed citations

20.

Nasevicius, Aidas, Jon D. Larson, & Stephen C. Ekker. (2000). Distinct Requirements for Zebrafish Angiogenesis Revealed by a VEGF-A Morphant. Yeast. 1(4). 294–301. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact